Lifecode Inc

Lifecode Inc., a research branch of MedGenome Inc., is dedicated to enhancing the lives of cancer patients by delivering patient-specific molecular information through advanced genomic technologies. With expertise in data science, computational biology, and machine learning, Lifecode translates complex genomic data into actionable insights for patients, payers, and providers.

Funded by Sequoia Capital and The Mayo Clinic, Lifecode operates as a CAP accredited and CLIA certified clinical laboratory, aiming to provide personalized cancer care through its flagship Lifecode Pan Cancer Somatic Panel. The company fosters a collaborative environment, seeking talented individuals who share its commitment to improving patient outcomes through genomics.

Generated from the website